N. Wong

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

M. Stockler, N. Pavlakis, R. Simes, 2015, Supportive Care in Cancer.

Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial

V. Gebski, N. Pavlakis, V. Ganju, 2016, British Journal of Cancer.

Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis

M. Stockler, J. Simes, P. Grimison, 2017, PharmacoEconomics.

Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.

V. Gebski, J. Mackey, D. Goldstein, 2014 .

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

M. Stockler, C. Gedye, I. McGregor, 2018, BMJ Open.

Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours

M. Stockler, I. Davis, P. Grimison, 2018, BMC Cancer.

Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours

M. Stockler, I. Davis, P. Grimison, 2018, BMC Cancer.